ReviewPharmacological reports : PR2024
Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.
Izabela Szpręgiel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it